These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 34310709)

  • 21. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
    Terraf P; Pareja F; Brown DN; Ceyhan-Birsoy O; Misyura M; Rana S; O'Reilly E; Carlo MI; Aghajanian C; Liu Y; Derakhshan F; Jayakumaran G; Weigelt B; Walsh M; Stadler Z; Offit K; Ladanyi M; Robson M; Zehir A; Reis-Filho JS; Mandelker D
    Ann Oncol; 2022 Apr; 33(4):426-433. PubMed ID: 35074424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline findings in patients with advanced malignancies screened with paired blood-tumour testing for personalised treatment approaches.
    Roggia C; Armeanu-Ebinger S; Gschwind A; Seibel-Kelemen O; Hertler S; Faust U; Liebmann A; Haack TB; Neumann M; Bonzheim I; Forschner A; Kopp HG; Herster F; Hartkopf A; Bitzer M; Malek NP; Brecht IB; Ruhm K; Möller Y; Löwenheim H; Ossowski S; Rieß OH; Schroeder C
    Eur J Cancer; 2023 Jan; 179():48-55. PubMed ID: 36495689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome analysis and knowledge-driven variant interpretation with TGex.
    Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
    BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.
    Jahn A; Rump A; Widmann TJ; Heining C; Horak P; Hutter B; Paramasivam N; Uhrig S; Gieldon L; Drukewitz S; Kübler A; Bermudez M; Hackmann K; Porrmann J; Wagner J; Arlt M; Franke M; Fischer J; Kowalzyk Z; William D; Weth V; Oster S; Fröhlich M; Hüllein J; Valle González C; Kreutzfeldt S; Mock A; Heilig CE; Lipka DB; Möhrmann L; Hanf D; Oleś M; Teleanu V; Allgäuer M; Ruhnke L; Kutz O; Knurr A; Laßmann A; Endris V; Neumann O; Penzel R; Beck K; Richter D; Winter U; Wolf S; Pfütze K; Geörg C; Meißburger B; Buchhalter I; Augustin M; Aulitzky WE; Hohenberger P; Kroiss M; Schirmacher P; Schlenk RF; Keilholz U; Klauschen F; Folprecht G; Bauer S; Siveke JT; Brandts CH; Kindler T; Boerries M; Illert AL; von Bubnoff N; Jost PJ; Metzeler KH; Bitzer M; Schulze-Osthoff K; von Kalle C; Brors B; Stenzinger A; Weichert W; Hübschmann D; Fröhling S; Glimm H; Schröck E; Klink B
    Ann Oncol; 2022 Nov; 33(11):1186-1199. PubMed ID: 35988656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additional germline findings from a tumor profiling program.
    Stjepanovic N; Stockley TL; Bedard PL; McCuaig JM; Aronson M; Holter S; Semotiuk K; Leighl NB; Jang R; Krzyzanowska MK; Oza AM; Gupta A; Elser C; Ahmed L; Wang L; Kamel-Reid S; Siu LL; Kim RH
    BMC Med Genomics; 2018 Aug; 11(1):65. PubMed ID: 30092803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline testing for homologous recombination repair genes-opportunities and challenges.
    Hirsch S; Gieldon L; Sutter C; Dikow N; Schaaf CP
    Genes Chromosomes Cancer; 2021 May; 60(5):332-343. PubMed ID: 33078493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer SIGVAR: A semiautomated interpretation tool for germline variants of hereditary cancer-related genes.
    Li H; Liu S; Wang S; Zeng Q; Chen Y; Fang T; Zhang Y; Zhou Y; Zhang Y; Wang K; Yan Z; Qiang C; Xu M; Chai X; Yuan Y; Huang M; Zhang H; Xiong Y
    Hum Mutat; 2021 Apr; 42(4):359-372. PubMed ID: 33565189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer.
    Lincoln SE; Nussbaum RL; Kurian AW; Nielsen SM; Das K; Michalski S; Yang S; Ngo N; Blanco A; Esplin ED
    JAMA Netw Open; 2020 Oct; 3(10):e2019452. PubMed ID: 33026450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic sequencing in cancer.
    Tuna M; Amos CI
    Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines.
    Matsui H; Hirata M
    Int J Hematol; 2024 May; 119(5):552-563. PubMed ID: 38492200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Clinical Genome and Ancestry Report: An interactive web application for prioritizing clinically implicated variants from genome sequencing data with ancestry composition.
    Lee IH; Negron JA; Hernandez-Ferrer C; Alvarez WJ; Mandl KD; Kong SW
    Hum Mutat; 2020 Feb; 41(2):387-396. PubMed ID: 31691385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria.
    Andoni T; Wiggins J; Robinson R; Charlton R; Sandberg M; Eeles R
    Sci Rep; 2022 Feb; 12(1):2507. PubMed ID: 35190596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Cancer Variant Pathogenicity Information Exchange (PeCanPIE): a cloud-based platform for curating and classifying germline variants.
    Edmonson MN; Patel AN; Hedges DJ; Wang Z; Rampersaud E; Kesserwan CA; Zhou X; Liu Y; Newman S; Rusch MC; McLeod CL; Wilkinson MR; Rice SV; Soussi T; Taylor JP; Benatar M; Becksfort JB; Nichols KE; Robison LL; Downing JR; Zhang J
    Genome Res; 2019 Sep; 29(9):1555-1565. PubMed ID: 31439692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing.
    Al-Shinnag M; Cheong PL; Goodwin A; Trent R; Yu B
    Pathology; 2024 Jun; 56(4):468-472. PubMed ID: 38627125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinatorial batching of DNA for ultralow-cost detection of pathogenic variants.
    Stoltze UK; Hagen CM; van Overeem Hansen T; Byrjalsen A; Gerdes AM; Yakimov V; Rasmussen S; Bækvad-Hansen M; Hougaard DM; Schmiegelow K; Hjalgrim H; Wadt K; Bybjerg-Grauholm J
    Genome Med; 2023 Mar; 15(1):17. PubMed ID: 36918911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study.
    Hutchcraft ML; Zhang S; Lin N; Pickarski JC; Belcher EA; Wei S; Bocklage T; Miller RW; Villano JL; Cavnar MJ; Kim J; Arnold SM; Ueland FR; Kolesar JM
    JCO Precis Oncol; 2024 Jan; 8():e2300266. PubMed ID: 38295319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives.
    Heald B; Pirzadeh-Miller S; Ellsworth RE; Nielsen SM; Russell EM; Beitsch P; Esplin ED; Nussbaum RL; Pineda-Alvarez DE; Kurian AW; Hampel H
    J Natl Cancer Inst; 2024 Feb; 116(2):334-337. PubMed ID: 37756683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.